Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harrow Inc
(NQ:
HROW
)
50.37
+0.62 (+1.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harrow Inc
< Previous
1
2
3
4
5
6
7
Next >
10 Health Care Stocks Whale Activity In Today's Session
May 03, 2024
Via
Benzinga
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
April 25, 2024
From
Harrow, Inc.
Via
Business Wire
Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying
April 25, 2024
Via
Benzinga
Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying
April 22, 2024
Via
Benzinga
Insiders Buying Greenwich LifeSciences And 2 Other Stocks
March 25, 2024
Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.
Via
Benzinga
Harrow: Q4 Earnings Insights
March 19, 2024
Via
Benzinga
Earnings Preview: Harrow Health
March 18, 2024
Via
Benzinga
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
April 02, 2024
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...
Via
Benzinga
INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
March 20, 2024
Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding.
Via
InvestorPlace
Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
March 20, 2024
Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning.
Via
InvestorPlace
Why Is Harrow (HROW) Stock Up 5% Today?
March 20, 2024
Harrow stock is up on Wednesday as investors in HROW shares react to the company's earnings report for the fourth quarter of 2023!
Via
InvestorPlace
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
March 20, 2024
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 20, 2024
Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning!
Via
InvestorPlace
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 20, 2024
U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023
March 19, 2024
HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
March 19, 2024
From
Harrow, Inc.
Via
Business Wire
Earnings Scheduled For March 19, 2024
March 19, 2024
Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
March 05, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
February 15, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Announces New Appointments to its Board of Directors
January 29, 2024
From
Harrow, Inc.
Via
Business Wire
Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
January 11, 2024
From
Harrow, Inc.
Via
Business Wire
Melt Pharmaceuticals Provides Corporate Update
January 03, 2024
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Harrow Partners with Leading Healthcare Market Access Technology Platforms
January 03, 2024
From
Harrow, Inc.
Via
Business Wire
7 Short-Squeeze Stocks That Are Screaming for Speculation
December 24, 2023
If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you.
Via
InvestorPlace
Harrow Completes Transfer of the TRIESENCE® New Drug Application
November 29, 2023
From
Harrow, Inc.
Via
Business Wire
Harrow to Present at Two Investor Conferences in November
November 20, 2023
From
Harrow, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 14, 2023
Via
Benzinga
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.